ロード中...
An update on the use of natalizumab in the treatment of multiple sclerosis: appropriate patient selection and special considerations
In the context of an increasing repertoire of multiple sclerosis (MS) therapeutics, choosing the appropriate treatment for an individual patient is becoming increasingly challenging. Natalizumab, a humanized monoclonal antibody directed against alpha4beta1 integrin, has proven short-term and long-te...
保存先:
| 出版年: | Patient Prefer Adherence |
|---|---|
| 第一著者: | |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Dove Medical Press
2015
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4446014/ https://ncbi.nlm.nih.gov/pubmed/26056435 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/PPA.S20791 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|